U.S., Zambia Sign Agreement For Partnership To End TB

The Mast: U.S., Zambia sign partnership to end TB
“The United States and Zambia have signed the Tuberculosis Accelerator Statement of Partnership to end TB in Zambia. The Statement of Partnership represents a joint approach to achieve Zambia’s 2022 United Nations High Level Meeting TB targets: 1) treat over 200,000 people with drug-susceptible TB; 2) treat 4,800 people with drug-resistant TB; and 3) put over 400,000 people on TB preventive therapy…” (Chakwe, 10/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.